News – Page 1087 – Endpoints News

SIGN UP

Looking for an I/O edge, Bristol-Myers fronts $105M to partner with Halozyme as Roche expands pact

8 years ago

Great data! Huge potential! (Too bad it failed the primary endpoint)

8 years ago

GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on

8 years ago

Convicted felon Martin Shkreli has finally talked his way behind bars

8 years ago

Martin Shkreli suddenly changes his tune on Clinton threat; Genenta adds $8M for gene therapy R&D

8 years ago

Otonomy brings out the ax after a catastrophic PhIII failure

8 years ago

Mylan attacks Allergan over its Mohawk-allied patent strategy — but the CEO is sticking to his guns

8 years ago

Searching for a few great drugs, BridgeBio bags $135M to back a fresh slate of R&D bets

8 years ago

As rivals look to carve up its blockbuster revenue, Novartis’ Cosentyx registers remarkably consistent effect for ...

8 years ago

Amicus scraps a top rare disease drug after it flunks a pivotal test — and shares spike

8 years ago

Scott Gottlieb is closing a big loophole in the orphan drug law

8 years ago

Gene therapy startup Rocket Pharma reverse merges with troubled Inotek after $25M raise

8 years ago

Another senior AstraZeneca exec jumps ship; Aldeyra shares soar on positive mid-stage data

8 years ago

ProQR spins out a new RNA biotech focused on CNS diseases

8 years ago

Alexion is reorganizing R&D, axing 600-plus jobs and moving HQ to Boston as execs prep deal spree

8 years ago

Sage’s quick flip into PhIII crashes as lead drug fails badly for rare type of seizures

8 years ago

WATCH: Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

8 years ago

Onxeo shares blitzed after PhIII liver cancer study flops

8 years ago

Struggling in R&D, GSK lines up an FDA pitch on COPD with mixed data

8 years ago

AbbVie stirs safety jitters after two patients die in ABT-494 study

8 years ago

Regeneron, Sanofi post good PhIII asthma data for Dupixent — but it’s losing its halo

8 years ago

Summit wins $62M BARDA contract, shares surge; Novartis adds new CGRP data

8 years ago

#ESMO17 roundup: Idera shares spike on early TLR9 combo data; Erytech touts pancreatic cancer PhIIb data

8 years ago

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn't refuse, including $20M in cash

8 years ago

First page Previous page 1084 1085 108610871088 1089 1090 Next page Last page